Endometriosis

New to The Street TV Announces its Four Business Guest Interviews, Episode 476 Airs on Bloomberg TV as A Sponsored Program, Tonight, Thursday, June 8, 2023, at 9:30 PM PT

Retrieved on: 
Thursday, June 8, 2023

New to The Street's TV episode 476 will air the following five (5) business interviews:

Key Points: 
  • New to The Street's TV episode 476 will air the following five (5) business interviews:
    1).
  • Vacation Property Management – The Compass Collection's interviews with Heather Plampin, President/CEO, and Matt Farhat, Head of Business Development.
  • Endometriosis affects millions of women globally, and a non-invasive diagnostic tool can assist patients in forecasting and managing the disease.
  • Recently, MIT University, through a business incubation program, started Gradient, now a $1B business entity focused on water-intensive sectors.

OBGYN CARE - The best of Obstetrics & Gynecology in Newport beach, Irvine, Orange County, California combined with the latest in Artificial Intelligence

Retrieved on: 
Wednesday, June 7, 2023

NEWPORT and IRVINE, Calif., June 7, 2023 /PRNewswire/ -- AI is revolutionizing all aspects of our lives and the medical field is no exception. With a wealth of international training and experience, we believe in using innovation to create a smarter model of obstetrics and gynecology that can continue to provide the very best results in an even more cost-effective and efficient manner.

Key Points: 
  • OBGYN CARE ( www.obgyn-care.net ) is a leading obstetrician-gynecologist enterprise with surgery supra-specialization in Southern California.
  • We are passionate about harnessing the responsible application of cutting-edge AI technology both into direct medical care and more efficient medical management.
  • As an independent entity in a field dominated by medical monoliths staffed with universal physicians, we remain focussed on our most important mission - the best patient-personalized individual care.
  • OBGYN CARE ( www.obgyn-care.net ) already offers the widest range of gynecological surgical procedures in Orange County, CA, mostly through Minimally Invasive and Robotic Surgery.

Aspira Women’s Health Appoints Dr. Winfred Parnell to its Board of Directors

Retrieved on: 
Monday, June 5, 2023

AUSTIN, Texas, June 05, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of Dr. Winfred Parnell as a new independent director on the Aspira Board of Directors, effective June 1, 2023.

Key Points: 
  • AUSTIN, Texas, June 05, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of Dr. Winfred Parnell as a new independent director on the Aspira Board of Directors, effective June 1, 2023.
  • “We are thrilled to welcome Dr. Parnell to our Board of Directors.
  • “As we expand our product portfolio, Dr. Parnell’s clinical, business, and board experience will be invaluable.”
    Dr. Winfred Parnell is a board-certified physician in obstetrics and gynecologic care.
  • Dr. Parnell noted, “I am honored to join the board of Aspira.

New to The Street Announces its Corporate Guests TV Interviews, Airing as Episodes 474 and 475 with Shows Starting on Saturday, June 3, 2023, at 3:30 PM ET

Retrieved on: 
Friday, June 2, 2023

Newsmax airs Episode 474 Saturday, June 3, 2023, at 3:30 PM ET, featuring the following Corporate Guests:

Key Points: 
  • Newsmax airs Episode 474 Saturday, June 3, 2023, at 3:30 PM ET, featuring the following Corporate Guests:
    2).
  • Precision Mapping Solutions – ProStar Holdings, Inc.'s (OTCQX: MAPPF) (TSXV: MAPS) (FSE: 5D00) ($MAPPF) interview with Page Tucker, Chief Executive Officer.
  • FOX Business Network airs Episode 475 Monday, June 5, 2023, at 10:30 PM PT, featuring the following Corporate Guests:
    2).
  • Gold/Silver Mining – Lahontan Gold Corp.'s (OTCQB: LGCXF) (TSXV: LG) ($LGCXF) interview with Kimberly Ann , Founder, CEO, President, and Director.

New York Liver and Pancreatic Cancer Surgeon, Dr. Dmitri Alden, Recognized as a 2023 Top Patient Rated Doctor by Find Local Doctors

Retrieved on: 
Friday, June 2, 2023

NEW YORK, June 2, 2023 /PRNewswire-PRWeb/ -- At his state-of-the-art practice, located in NYC, Dr. Dmitri Alden handles many issues affecting the liver, pancreas, and biliary system, including surgery for complex cancers. Find Local Doctors has selected Dr. Dmitri Alden for this award as a result of his five-star ratings and exceptional reviews from satisfied patients across multiple online sources. Find Local Doctors is a user-friendly online directory, connects consumers with skilled physicians in their area who are well-known for their expertise. Widely recognized in his field as one of the top specialists and surgeons in the country, Dr. Dmitri Alden is always at the forefront of medical innovation. He has extensive experience in traditional operations on the liver and pancreas and also separate expert training in performing laparoscopic and robotic surgery for liver cancer, pancreatic cancer and endometriosis of the liver and diaphragm. Patients from all around the world seek out treatment from Dr. Alden, and he has been identified as America's Top 100 Surgeons for his achievements and featured consecutively since 2015 as one of New York Magazine's Best Doctors.

Key Points: 
  • Find Local Doctors has selected Dr. Dmitri Alden for this award as a result of his five-star ratings and exceptional reviews from satisfied patients across multiple online sources.
  • Find Local Doctors is a user-friendly online directory, connects consumers with skilled physicians in their area who are well-known for their expertise.
  • He has extensive experience in traditional operations on the liver and pancreas and also separate expert training in performing laparoscopic and robotic surgery for liver cancer , pancreatic cancer and endometriosis of the liver and diaphragm.
  • He speaks fluent English, Russian, French, and German, and his practice is located at 186 E 76th Street in New York, NY.

Ivy Fertility Acquires NOVA IVF

Retrieved on: 
Wednesday, May 31, 2023

Ivy Fertility, a globally-recognized innovator in advanced reproductive technology, in-vitro fertilization (IVF), and third-party reproduction, announced today it has acquired NOVA IVF based in Mountain View, CA.

Key Points: 
  • Ivy Fertility, a globally-recognized innovator in advanced reproductive technology, in-vitro fertilization (IVF), and third-party reproduction, announced today it has acquired NOVA IVF based in Mountain View, CA.
  • NOVA IVF is a Mountain View, CA-based fertility and IVF practice led by Richard Schmidt, M.D.
  • “Ivy Fertility is the perfect partner for the future of our practice,” said Richard Schmidt, M.D., Director of NOVA IVF.
  • “With the addition of NOVA IVF, Ivy Fertility centers now represent more IVF cycles in California than any other fertility network.

Global Rigid Endoscopes Market to 2030: Preference for Minimally Invasive Surgical Techniques over Standard Surgeries Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 30, 2023

The high burden of cancer, gynecological disorders, urothelial disorders, and others are contributing to the demand for surgeries, further supporting the demand for rigid endoscopes in the market.

Key Points: 
  • The high burden of cancer, gynecological disorders, urothelial disorders, and others are contributing to the demand for surgeries, further supporting the demand for rigid endoscopes in the market.
  • The COVID-19 pandemic had a negative impact on the market owing to the cancellation and decline in elective procedures during the pandemic.
  • The preference for minimally invasive surgical techniques over standard surgeries, greater patient satisfaction, enhanced economic viability, and shorter hospital stays are expected to support the demand for endoscopic surgeries and thus support the market of rigid endoscopes.
  • This high share is attributable to the significant number of endoscopic surgeries conducted in outpatient facilities, which is supporting the segment market growth.

Adenomyosis: from symptoms to treatment, two women's health experts explain this little known condition

Retrieved on: 
Saturday, May 27, 2023

Yet many people have never heard of this condition, despite it affecting as many as one in five women.

Key Points: 
  • Yet many people have never heard of this condition, despite it affecting as many as one in five women.
  • The severity of symptoms varies between patients – up to one-third of women with adenomyosis may have minimal or no symptoms at all.
  • Women with adenomyosis who do become pregnant have an increased risk of miscarriage, pre-term delivery, pre-eclampsia and bleeding after delivery.

What causes adenomyosis?

    • In people with adenomyosis, endometrium-like cells are found in the wrong place – the myometrium.
    • Although a large number of women with adenomyosis have endometriosis as well, adenomyosis is a distinct disease from endometriosis.
    • Read more:
      Adenomyosis causes pain, heavy periods and infertility but you've probably never heard of it

Diagnosis options are changing and improving

    • Recent years have seen increased diagnoses with the development of imaging technologies such as MRI and detailed pelvic ultrasound.
    • Although adenomyosis is now commonly identified without the need for a hysterectomy, doctors are still working towards developing a standardised method for non-surgical diagnosis.

Adenomyosis is a complex condition

    • Adenomyosis can be further classified depending on the depth of endometrial-like tissue invasion into the myometrium.
    • We don’t yet understand why some women develop adenomyosis, though evidence shows there is an increasing prevalence with age.
    • It’s possible that a variety of mechanisms may contribute, and that there is not one common disease-causing factor behind adenomyosis.

How is adenomyosis treated?

    • Treatments that work for some women don’t for others, adding weight to the argument that there’s more than one type of adenomyosis.
    • Treatment strategies should be tailored to patients, depending on their fertility wishes and symptoms.
    • If medical treatments are not providing adequate relief from symptoms, there are surgical options, namely removal of the focal lesions or a hysterectomy.

What lies ahead?

    • There is also a lack of knowledge and awareness around adenomyosis among many healthcare professionals and the public.
    • This needs to change so we can improve our understanding of the condition, diagnosis and treatment options.

Burjeel Medical City Launches Advanced Gynecology Institute to Offer Complex Care Solutions for Women

Retrieved on: 
Tuesday, May 23, 2023

Burjeel Medical City, the flagship facility of Burjeel Holdings, has launched an Advanced Gynecology Institute (AGI) designed to offer multidisciplinary healthcare solutions to women of all ages.

Key Points: 
  • Burjeel Medical City, the flagship facility of Burjeel Holdings, has launched an Advanced Gynecology Institute (AGI) designed to offer multidisciplinary healthcare solutions to women of all ages.
  • Three specialized clinics of the hospital - Gynecological Oncology, IFEM Endo Middle East Clinic, and Complex Gynecology Care - will come under AGI.
  • Dr. Maitha Bint Salem Al Shamsi, Minister of State, UAE Government, inaugurating Advanced Gynecology Institute at Burjeel Medical City (Photo: AETOSWire)
    Prof. Horace Roman, a renowned endometriosis surgeon and founding member of IFEM Endo, will be heading the institute.
  • “The institute showcases our commitment to excellence and cements our position as a leader in complex care.

IceCure Medical Reports First Quarter 2023 Financial & Operational Results

Retrieved on: 
Monday, May 22, 2023

Builds Momentum as ProSense is Featured at Medical Conferences and Educational Courses

Key Points: 
  • Builds Momentum as ProSense is Featured at Medical Conferences and Educational Courses
    CAESAREA, Israel, May 22, 2023 /PRNewswire/-- IceCure Medical Ltd. (the "Company" or "IceCure") (Nasdaq: ICCM) (TASE: ICCM) developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today reported financial results as of and for the three months ended March 31, 2023 as well as operational and recent corporate developments.
  • We believe this momentum in the market is bolstered by a broader trend toward minimally invasive procedures," stated IceCure CEO Eyal Shamir.
  • Company's Ordinary Shares to Trade Exclusively on Nasdaq: IceCure announced its voluntary delisting from the Tel Aviv Stock Exchange ("TASE").
  • In the first quarter of 2023, sales increased in the U.S. and Europe relative to the same quarter last year.